Ken Griffin Reviva Pharmaceuticals Holdings, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 474,600 shares of RVPH stock, worth $389,172. This represents 0.0% of its overall portfolio holdings.
Number of Shares
474,600
Previous 351,400
35.06%
Holding current value
$389,172
Previous $607,000
25.86%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RVPH
# of Institutions
55Shares Held
7.45MCall Options Held
938KPut Options Held
40.8K-
Vanguard Group Inc Valley Forge, PA1.8MShares$1.48 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.53MShares$1.26 Million0.0% of portfolio
-
Diadema Partners LP Morristown, NJ651KShares$533,5920.16% of portfolio
-
Tang Capital Management LLC San Diego, CA510KShares$418,4690.03% of portfolio
-
Geode Capital Management, LLC Boston, MA419KShares$343,6930.0% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $16.8M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...